I was just noticing the stock up and noticed the PR. Its interesting that while the drug had some safety concerns (monkeys) it appears to be clean and with no added side effects (so far anyway). If SVR rates are better then T but they do it through 48 weeks of SOC does anyone have a sense for market share of RG7128 vs T (excluding Merck for now) if both are on the market?
News 
Market Data 
Discover 
